StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the stock.
Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.
Check Out Our Latest Analysis on STRM
Streamline Health Solutions Trading Up 3.1 %
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last announced its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The business had revenue of $4.48 million during the quarter.
About Streamline Health Solutions
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
Featured Stories
- Five stocks we like better than Streamline Health Solutions
- Stock Market Upgrades: What Are They?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Business Services Stocks Investing
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How to Invest in the FAANG Stocks
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.